Published 2020-05-01
“…Helen Phillips-Jackson,1 Clive Hallam,2 Niamh Cullen,3 Terry Pearson,4 Mark Gilman,5 Li Li,6 Paul Musgrave7 1Working Group on Innovation Assessment, Expert Faculty on Commissioning, London, UK; 2Richmond and Wandsworth Council, London, UK; 3Public Health, Calderdale, UK; 4
Northamptonshire County Council, Northamptonshire, UK; 5Discovering Health, Manchester, UK; 6Applied Strategic, London, UK; 7Public Health, Cumbria, UKCorrespondence: Paul MusgravePublic Health, Cumbria, UKEmail commissioners@expertfaculty.orgObjective: To assess budget impact of the introduction of prolonged-release buprenorphine (PRB) for care of opioid use disorder (OUD) over 1 year in a defined population.Materials and Methods: A healthcare perspective, decision-tree model analysis of the cost of OUD care for a standard population was prepared to compare two scenarios: treatment of a population under the existing standard of care, or with the addition of PRB. …”
Get full text
Article